Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

CUSIP: 23285D109

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-195,930
SEC-reported price per share
$5.96
Number of holders
19
Value change
-$868,178
Number of buys
5
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
129,694,583

Security key

23285D109

Report period

Q3 2026

Institutions

19

Top holders

10

Ownership snapshot

Top reported holders of CTKB - Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
5/15
Latest evidence
18 Aug 2026
13F 13D/G 3/4/5 Lead comparable stake: 7.2% 10 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 7.2%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 7.2%
MILLENNIUM MANAGEMENT LLC 7.2%
Boston Partners 5.9%
Topline Capital Management, LLC 5.3%
BROWN CAPITAL MANAGEMENT LLC 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
7.2%
Reported 13D/G · 30 Jun 2026
$42,433,388
9,578,643 shares
— 30 Jun 2026
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
7.2%
Reported 13D/G · 30 Jun 2026
$41,367,384
9,338,010 shares
+$6,490,437 30 Jun 2026
Boston Partners
13F 13D/G
Company
5.9%
Reported 13D/G · 30 Jun 2026
$33,942,877
7,660,943 shares
— 30 Jun 2026
Topline Capital Management, LLC
13D/G 13F
Company
5.3%
Reported 13D/G · 25 Sep 2025
$28,140,515
6,780,847 shares
$0 25 Sep 2025
BROWN CAPITAL MANAGEMENT LLC
13D/G
3.9%
Reported 13D/G · 30 Sep 2025
$17,204,316
4,958,016 shares
-$8,695,650 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P.
3/4/5
Director, 10%+ Owner
—
denominator unverified
$127,120,013
13,381,054 shares
— 14 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
19
Shares
124,601
Rows available
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q4 2025 Across Filers

Q4 2025 holders
155
Q3 2026 holders
19
Holder diff
-136
Investor Q4 2025 Shares Q3 2026 Shares Share Diff Share Chg % Q4 2025 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .